Industries

Why GW Pharmaceuticals, Revance Therapeutics, and Allergan Are Today's 3 Best Stocks

The health-care sector may have been a major crutch for the broad-based S&P 500 during the past two months, but today it was its greatest...

Gilead Sciences Drops Jaws With a 209% Increase in Q1 Net Income

Infectious disease-focused biopharmaceutical company Gilead Sciences did nothing short of dazzle Wall Street after the closing bell by ...

Should You Stay the Course With This Select-Service Hotel?


Source: La Quinta.

More doesn't mean better, and select-service hotels are equally, if not more attractive than their...

YPF's New Deal With Chevron: Time To Buy?

Chevron recently agreed to spend $1.6 billion along with YPF to continue the development of Argentina's exciting Vaca Muerta shale...